Milad Shirvaliloo | Cancer Epigenetics | Best Researcher Award 

Published on by World Top Scientists

Dr. Milad Shirvaliloo | Cancer Epigenetics | Best Researcher Award 

Research Associate | Iran University of Medical Sciences | Iran

Dr. Milad Shirvaliloo is an accomplished physician–researcher specializing in epigenetics with a focus on cancer and pulmonary medicine. Holding a Doctor of Medicine and a Master of Business Administration in Health Sciences, he combines clinical expertise with research innovation to advance precision medicine. As a Postgraduate Researcher at the Finetech in Medicine Research Center, he leads studies on nanoparticle-based therapeutic interventions and their effects on histone acetylation in cancer. Dr. Shirvaliloo has authored more than forty peer-reviewed publications and a book chapter, contributing extensively to understanding molecular and epigenetic mechanisms in disease pathogenesis. His scholarly output includes first-author and single-author papers in leading journals, where he explores the roles of histone modifications, long noncoding RNAs, and nanobiosensor technologies in diagnostics and therapeutics. He has demonstrated academic leadership as an Editorial Board Member for Epigenomics and Molecular and Cellular Biochemistry and has served as a peer reviewer for over sixty high-impact journals. Recognized for his scientific excellence and editorial contributions, he has received the Best Researcher Award for his outstanding achievements in biomedical science. His ongoing work reflects a strong commitment to translational research, interdisciplinary collaboration, and mentorship of emerging scientists. With a clear vision for integrating molecular biology, nanotechnology, and clinical application, Dr. Shirvaliloo exemplifies the future of innovative medical research and continues to make significant contributions to global health advancement.

Profiles: Google Scholar | Scopus | ORCID

Featured Publications

1. Heris, R. M., Shirvaliloo, M., Abbaspour-Aghdam, S., Hazrati, A., Shariati, A., & others. (2022). The potential use of mesenchymal stem cells and their exosomes in Parkinson’s disease treatment. Stem Cell Research & Therapy, 13(1), 371.

2. Sheervalilou, R., Shirvaliloo, M., Dadashzadeh, N., Shirvalilou, S., Shahraki, O., & others. (2020). COVID‐19 under spotlight: A close look at the origin, transmission, diagnosis, and treatment of the 2019‐nCoV disease. Journal of Cellular Physiology, 235(12), 8873–8924.

3. Aghbash, P. S., Eslami, N., Shirvaliloo, M., & Baghi, H. B. (2021). Viral coinfections in COVID‐19. Journal of Medical Virology, 93(9), 5310–5322.

4. Shirvalilou, S., Khoei, S., Esfahani, A. J., Kamali, M., Shirvaliloo, M., & others. (2021). Magnetic hyperthermia as an adjuvant cancer therapy in combination with radiotherapy versus radiotherapy alone for recurrent/progressive glioblastoma: A systematic review. Journal of Neuro-Oncology, 152(3), 419–428.

5. Razlansari, M., Jafarinejad, S., Rahdar, A., Shirvaliloo, M., Arshad, R., & others. (2023). Development and classification of RNA aptamers for therapeutic purposes: An updated review with emphasis on cancer. Molecular and Cellular Biochemistry, 478(7), 1573–1598.*

Dr. Milad Shirvaliloo’s pioneering research in epigenetics and nanomedicine bridges molecular science with clinical application, driving innovations in cancer and pulmonary disease diagnostics and therapies. His work advances precision medicine and fosters global scientific collaboration, contributing to more effective, personalized healthcare solutions.

Sharadamma Narayanaswamy | Molecular Biology | Best Researcher Award

Published on by World Top Scientists

Dr. Sharadamma Narayanaswamy | Molecular Biology | Best Researcher Award

Associate Professor at REVA University | India

Dr. Sharadamma Narayanaswamy is an accomplished researcher and academician with extensive expertise in biochemistry and molecular biology. Her career spans significant contributions in enzyme studies, microbial research, and the biochemical characterization of nucleoid-associated proteins in Mycobacterium tuberculosis. With strong experience in advanced techniques such as protein purification, cloning, expression, site-directed mutagenesis, and immunological assays, she has established herself as a skilled experimentalist and mentor. She has guided numerous postgraduate students, successfully completed funded projects, and actively engaged in developing innovative research initiatives with societal and scientific relevance. Her teaching experience across leading institutions has enriched her ability to integrate research with pedagogy, inspiring students to pursue scientific inquiry. Recognized with awards such as Best Researcher, she has consistently demonstrated excellence and dedication to her field. Her commitment to research, teaching, and mentorship highlights her as a valuable contributor to advancing knowledge in biochemistry.

Professional Profile 

Scopus Profile 

Education

Dr. Sharadamma Narayanaswamy has pursued a strong academic foundation in the field of biochemistry and allied sciences. She earned her Ph.D. in Biochemistry from Bangalore University, where she worked extensively on enzyme studies and microbial research. She also holds a Post-Doctoral Research Associate fellowship from the Indian Institute of Science, Bengaluru, where she gained advanced training in molecular biology and protein chemistry. Her academic qualifications further include an M.Sc. in Biochemistry, B.Ed., and successful completion of SLET/NET, which reflect her comprehensive preparation for both teaching and research. Through her academic journey, she developed a strong expertise in enzymology, protein chemistry, and microbial biochemistry. Her advanced education and specialized training in cutting-edge techniques have enabled her to establish a career combining research, teaching, and mentoring. These academic achievements laid the groundwork for her impactful contributions in higher education and scientific research.

Experience

Dr. Sharadamma Narayanaswamy has over two decades of teaching and research experience across reputed institutions. She has served as a guest faculty, assistant professor, and now as an associate professor in the Department of Biochemistry at REVA University. In these roles, she has handled diverse subjects including biomolecules, clinical biochemistry, molecular biology, recombinant DNA technology, and endocrinology, while mentoring postgraduate students in research projects. Her career has also involved guiding seminars, practical training, and organizing academic activities, which demonstrate her ability to integrate classroom teaching with applied scientific skills. In addition to her teaching, she has actively contributed as a research mentor by supervising funded projects and student research initiatives. Her rich professional experience reflects a balance of pedagogy, research, and leadership, enabling her to influence both academic learning and scientific advancement. She continues to be a committed educator and researcher, shaping future scientists.

Research Focus

Dr. Sharadamma Narayanaswamy’s research interests lie at the intersection of biochemistry, enzymology, and molecular biology, with a focus on protein characterization and microbial biochemistry. Her early research included purification and kinetic studies of enzymes such as β-amylase, followed by doctoral work on tannin-degrading enzymes from soil microorganisms. As a postdoctoral researcher, she advanced to studying nucleoid-associated proteins from Mycobacterium tuberculosis, exploring their roles in DNA interactions and cellular regulation. She has developed expertise in molecular cloning, protein purification, EMSA, mutagenesis, and advanced biochemical assays. More recently, her work has expanded into applied research addressing challenges such as pest management using biochemical approaches. She has successfully completed institutional and externally funded projects, emphasizing both fundamental and applied dimensions of science. Her research reflects a deep commitment to solving scientific problems with societal impact, while contributing to the broader understanding of biochemical mechanisms and microbial systems.

Award and Honor

Dr. Sharadamma Narayanaswamy has been recognized for her significant contributions to research and education through several awards and honors. She received the Research Associate fellowship from the Department of Biotechnology, Government of India, which allowed her to undertake advanced postdoctoral work at the Indian Institute of Science. She has been honored with the Best Student Research Project Award by InSc and multiple recognitions for guiding innovative postgraduate research, including the Best M.Sc. Student Project under government-funded programs. Notably, she was awarded the Best Researcher Award at REVA University, acknowledging her sustained excellence in research and mentorship. These achievements reflect her ability to contribute to both academic and applied research while nurturing young scientists. Her recognition at institutional, state, and national levels highlights her reputation as a dedicated researcher and teacher. The awards stand as a testament to her hard work, innovation, and lasting impact in the field of biochemistry.

Publication Top Notes

  • Title: Biochemical profiling of plant latex Euphorbia hirta and Croton bonplandianum: Unveiling the nuclease and protease activity

  • Authors: Sharadamma Narayanaswamy, Nagesh Babu Rangappa, B M Chaithanya Rai, Likhitha J, Debasree Basu Mukherjee

  • Year: 2025

Conclusion

The publication “Biochemical profiling of plant latex Euphorbia hirta and Croton bonplandianum: Unveiling the nuclease and protease activity” highlights the potential of plant latex as a natural source of bioactive enzymes with significant biochemical applications. By uncovering nuclease and protease activities, this research contributes to the growing body of evidence supporting the therapeutic and industrial relevance of plant-derived biomolecules. Though still in the early stages of citation and recognition, the study demonstrates innovation and provides a foundation for future exploration into medicinal plant biochemistry. It reflects the authors’ commitment to advancing knowledge in enzyme research and opens new avenues for biotechnological and pharmaceutical applications.

Dr. Javier Crespo | Medicine and Dentistry | Best Researcher Award

Published on by World Top Scientists

Dr. Javier Crespo | Medicine and Dentistry | Best Researcher Award

Professor at IDIVAL, Spain

Professor Javier Crespo is a distinguished physician-scientist and academic leader in the field of digestive and liver diseases. Currently a Professor of Medicine at the University of Cantabria and Director of the Translational Research in Digestive Pathology group at IDIVAL, he has made significant contributions through over 400 original publications, more than 120 clinical trials, and leadership in numerous national and international research projects. With an H-index of 70 and over 30,000 citations, his work has had a profound global impact. He has played a pivotal role in national health strategies, including Spain’s Hepatitis C elimination plan, and served as President of major professional societies such as SEPD. A mentor to numerous doctoral and master’s students, he has also received multiple prestigious awards for his contributions to medicine and research. His leadership at Marqués de Valdecilla University Hospital earned repeated national recognition for excellence in digestive and hepatitis care.

Professional Profile 

Google Scholar
Scopus Profile
ORCID Profile 

Education

Professor Javier Crespo earned his Degree in Medicine and General Surgery from the University of Cantabria with an Outstanding qualification. He later obtained his Doctorate in Medicine in 1993, receiving the Extraordinary Doctorate Award for academic excellence. His formal education laid a strong foundation for a career marked by clinical rigor and academic depth. In addition to his medical qualifications, he has been accredited as a Professor by ANECA (the Spanish National Agency for Quality Assessment and Accreditation). His academic journey reflects not only excellence in performance but also an enduring commitment to scientific learning and advancement. His scholarly trajectory is rooted in a lifelong dedication to the field of hepatology and digestive pathology, with an early focus on merging basic medical science with clinical research. These formative years have played a crucial role in shaping his influential career in medicine, teaching, and research.

Professional Experience

Professor Crespo has held several prestigious positions throughout his career. He is a Professor of Medicine at the University of Cantabria and Director of the Translational Research in Digestive Pathology group at IDIVAL. He served as Head of the Digestive Service at Marqués de Valdecilla University Hospital from 2010 to 2024. Additionally, he has played strategic roles in healthcare governance, including being a member of Spain’s National Strategic Plan against Hepatitis C since 2015 and coordinator of the AEEH National Liver Health Plan Challenge 2032. His leadership extends to professional societies—he served as President of the Spanish Society of Digestive Pathology (SEPD), President of the National Digestive Commission, and Secretary of the Spanish Association for the Study of the Liver. His professional career reflects a unique blend of clinical excellence, policy leadership, academic mentoring, and research management, making him one of the most respected figures in his specialty.

Research Interest

Professor Crespo’s primary research interests center around digestive and liver diseases, with a particular focus on hepatitis C, liver cirrhosis, and inflammatory bowel diseases. He has led more than 120 clinical trials across Phases I–III and participated in 15 national and 8 international competitive research projects. His translational approach bridges laboratory findings with clinical application, especially in hepatology. Under his leadership, the IDIVAL research group has produced high-impact findings in digestive pathology and liver disease progression. He has authored over 400 original scientific articles, with a strong presence in high-impact journals. His work is cited more than 30,000 times, and he holds an H-index of 70, underscoring his global influence. He is also actively involved in supervising doctoral and postgraduate theses, reflecting his dedication to advancing the next generation of researchers in gastroenterology. His research has contributed significantly to public health, particularly in the management and elimination of hepatitis C.

Award and Honor

Professor Javier Crespo has received numerous national and international awards that recognize both his scientific excellence and public health impact. Among his most prestigious accolades are the Elimination Champions 2023 International Award, granted by the Coalition for Global Hepatitis Elimination, and the International Award at the VI LIFE Forum for HCV Elimination in Lima (2024). Nationally, he has been honored with the Commendation of the Civil Order of Health, the SEPD Gold Medal, and the ACAD Gold Medal. He was also named an Illustrious Torrelaveguense in 2024. Under his leadership, the Digestive Service at Marqués de Valdecilla University Hospital received the Best in Class Award for several consecutive years for excellence in digestive and hepatitis care. His honors reflect not only scientific merit but also his dedication to clinical service and public health leadership, making him one of the most decorated professionals in his field.

Conclusion

In conclusion, Professor Javier Crespo is a highly accomplished and impactful leader in the fields of gastroenterology and hepatology. His career combines outstanding academic achievement, clinical leadership, and translational research excellence. With more than 30,000 citations and an H-index of 70, his scientific contributions have shaped current practices in liver disease treatment and public health strategies. He has held top-level positions in hospitals, universities, research institutes, and national health commissions, evidencing his multifaceted influence. Through his mentorship, he has cultivated a generation of researchers and clinicians, further extending his legacy. His work has not only garnered national and international recognition through prestigious awards but has also led to meaningful improvements in patient care, especially in hepatitis C management. Professor Crespo exemplifies the qualities of a visionary researcher, a compassionate physician, and a dedicated educator—making him exceptionally worthy of recognition such as the Best Researcher Award.

Publications Top Notes

  • Carvedilol vs. propranolol for the prevention of decompensation and mortality in patients with compensated and decompensated cirrhosis

    • Authors: Not listed

    • Year: 2025

    • Citations: 3

  • Letter to the Editor: Optimizing MASLD treatment—A “lead-in phase” before resmetirom

    • Authors: Not listed

    • Year: Not listed

    • Citations: 1

  • Comprehensive Diagnosis of Viral Hepatitis in Spain: Bases for Implementation

    • Authors: Not listed

    • Year: 2025

  • Unraveling MASLD: The Role of Gut Microbiota, Dietary Modulation, and AI-Driven Lifestyle Interventions

    • Authors: Not listed

    • Year: Not listed

    • Citations: 1

  • A multisociety Delphi consensus statement on new fatty liver disease nomenclature

    • Authors: ME Rinella, JV Lazarus, V Ratziu, SM Francque, AJ Sanyal, F Kanwal, …

    • Year: 2023

    • Citations: 4,096

  • Host recognition of bacterial muramyl dipeptide mediated through NOD2: implications for Crohn’s disease

    • Authors: N Inohara, Y Ogura, A Fontalba, O Gutierrez, F Pons, J Crespo, K Fukase, …

    • Year: 2003

    • Citations: 2,245

  • Modeling NAFLD disease burden in 8 countries (2016–2030)

    • Authors: C Estes, QM Anstee, MT Arias-Loste, H Bantel, S Bellentani, J Caballeria, …

    • Year: 2018

    • Citations: 2,027

  • A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis

    • Authors: HSA Newsome, PN Buchholtz, K Cusi, M Linder, T Okanoue, V Ratziu, S Sanyal, …

    • Year: 2021

    • Citations: 1,673

  • Obeticholic acid for the treatment of NASH: Phase 3 trial analysis

    • Authors: ZM Younossi, V Ratziu, R Loomba, M Rinella, QM Anstee, Z Goodman, …

    • Year: 2019

    • Citations: 1,286

  • Elafibranor resolves NASH without fibrosis worsening

    • Authors: SA Ratziu, V Harrison, S Francque, P Bedossa, P Lehert, L Serfaty, …

    • Year: 2016

    • Citations: 1,217

  • Sofosbuvir and ribavirin in HCV genotypes 2 and 3

    • Authors: ER Zeuzem, S Dusheiko, GM Salupere, R Mangia, A Flisiak, RH Hyland, …

    • Year: 2014

    • Citations: 1,048

  • A Phase 3 Trial of Resmetirom in NASH with Liver Fibrosis

    • Authors: Not listed

    • Year: 2024

    • Citations: 983

  • Gene expression of TNF-α and TNF receptors in NASH patients

    • Authors: J Crespo, A Cayón, P Fernández‐Gil, M Hernández‐Guerra, M Mayorga, …

    • Year: 2001

    • Citations: 971

  • Advancing the global public health agenda for NAFLD: Consensus statement

    • Authors: JV Lazarus, HE Mark, QM Anstee, JP Arab, RL Batterham, L Castera, …

    • Year: 2022

    • Citations: 683

Dr. Laura Cerchia | translational cancer research | Best Researcher Award

Published on by World Top Scientists

Dr. Laura Cerchia | translational cancer research | Best Researcher Award

PI, Group Leader at Institute of Endotypes in Oncology, Metabolism and Immunology “G. Salvatore”, National Research Council, Italy

Dr. Laura Cerchia is a leading researcher in cancer-targeting RNA aptamer technologies, serving as Group Leader at the Institute of Endotypes in Oncology, Metabolism and Immunology (CNR, Italy). She pioneered the cell-SELEX method, widely adopted across international labs, and developed multiple aptamers targeting tumor biomarkers such as EGFR, AXL, and PDGFRβ. These aptamers have significant applications in imaging, immunotherapy, and targeted drug delivery, with some now used globally in advanced nanomedicine platforms. Author of over 90 peer-reviewed publications with an H-index of 36, she also holds four international patents. Dr. Cerchia has received numerous grants and serves on several national and international scientific committees, including Horizon Europe’s PHIRE project. Her expertise is recognized through roles as evaluator, editorial board member, and scientific advisor. Her work bridges fundamental research and therapeutic innovation, making her a key figure in translational oncology and a strong candidate for the Best Researcher Award.

Professional Profile 

Scopus Profile
ORCID Profile 

Education

Dr. Laura Cerchia earned her PhD in Biochemical Sciences, building a strong academic foundation in molecular biology and biochemistry. Her educational background equipped her with expertise in RNA biology, molecular diagnostics, and therapeutic development. Her advanced training allowed her to explore the structural and functional aspects of nucleic acids, which later became central to her innovative work in aptamer development. During her academic years, she developed an early interest in translational research, which led her to specialize in the design of synthetic oligonucleotides for medical applications. Her doctoral and postdoctoral studies laid the groundwork for her pioneering approach in using aptamers for targeted cancer therapy. Her education not only deepened her scientific knowledge but also instilled a critical problem-solving mindset that continues to influence her research directions. Her scholarly path reflects a combination of academic rigor and innovative thinking, forming the basis for her future contributions to biomedical science.

Professional Experience

Dr. Laura Cerchia is currently Group Leader at the Institute of Endotypes in Oncology, Metabolism and Immunology “G. Salvatore” (IEOMI) within the National Research Council of Italy (CNR). Her professional journey has been marked by impactful roles in both scientific leadership and collaborative research. She developed the widely used cell-SELEX procedure and generated several clinically relevant RNA aptamers targeting key tumor markers. Beyond laboratory research, Dr. Cerchia serves on editorial boards of journals such as Scientific Reports and Molecules, and holds evaluative and advisory roles in national and international research bodies, including the Horizon Europe-funded PHIRE project. Her career reflects a balance of scientific innovation, project management, and institutional leadership. She has successfully secured multiple research grants, built interdisciplinary teams, and advanced new diagnostic and therapeutic approaches. Her professional experience showcases her ability to lead complex research initiatives and influence the broader scientific and clinical communities.

Research Interest

Dr. Cerchia’s research focuses on the development of nuclease-resistant RNA aptamers for cancer theranostics, therapeutics, and targeted drug delivery. She is especially interested in the use of aptamers as precision tools for recognizing and binding specific biomarkers in tumors, such as EGFR, AXL, and PDGFRβ. Her work involves designing aptamers that can be used for in vitro and in vivo imaging, antagonistic therapies, and as carriers for chemotherapeutics, small molecule inhibitors, siRNAs, or photosensitizers. Her innovations in cell-SELEX have enabled the selection of highly specific aptamers against aggressive cancer types like glioblastoma, NSCLC, and triple-negative breast cancer (TNBC). She is also exploring the potential of aptamers in immunotherapy, including their integration with nanomedicine platforms. Her interest lies in translating basic molecular discoveries into clinical applications, with a strong focus on personalized medicine. Overall, her research aims to bridge gaps between molecular biology, oncology, and therapeutic delivery systems.

Award and Honor

Dr. Laura Cerchia has received multiple national and international recognitions for her contributions to cancer research and aptamer technology. She is the recipient of prestigious research grants and has been invited to serve on scientific evaluation panels, including for the Wellcome Trust (UK), ANR SHAMS, PRIN, and Horizon Europe projects. In 2018, she achieved the National Scientific Qualification, allowing her to function as a Full Professor in general and clinical pathology within Italian universities—an acknowledgment of her academic and professional excellence. She also serves as President and expert evaluator for PRIN 2022 PNRR – ERC Sector LS1, reinforcing her leadership role in shaping national research priorities. Her aptamers are cited and utilized worldwide, further validating the high translational value of her work. In addition to her editorial board positions, these honors demonstrate her broad influence, scientific credibility, and sustained contributions to advancing biomedical research on both national and international levels.

Conclusion

Dr. Laura Cerchia exemplifies the qualities of a world-class biomedical researcher through her pioneering work in RNA aptamer technologies, extensive publication record, and active leadership in the international scientific community. With a robust educational background, decades of impactful professional experience, and deep research expertise, she has made significant contributions to translational cancer therapy. Her innovations have enabled more precise targeting of tumors, enhancing both diagnostic and therapeutic capabilities. Her work has not only influenced academic circles but also spurred technological advances in nanomedicine and drug delivery. The widespread adoption of her aptamers across global research groups attests to the relevance and utility of her discoveries. Coupled with numerous awards, advisory roles, and editorial contributions, her profile reflects excellence, leadership, and a forward-looking vision in biomedical science. Dr. Cerchia’s continued efforts make her a strong candidate for high honors such as the Best Researcher Award and a role model in scientific innovation.

Publications Top Notes

  • Title: A novel therapeutic approach targeting PD-L1 in HNSCC and bone marrow-derived mesenchymal stem cells hampers pro-metastatic features in vitro: perspectives for blocking tumor-stroma communication and signaling
    Authors: Not listed
    Year: 2025

  • Title: A novel CD44-targeting aptamer recognizes chemoresistant mesenchymal stem-like TNBC cells and inhibits tumor growth
    Authors: Not listed
    Year: 2025

  • Title: Preclinical Toxicological Characterization of Porphyrin-Doped Conjugated Polymer Nanoparticles for Photodynamic Therapy
    Authors: Not listed
    Year: 2025

  • Title: Urine-Stable Aptamer-Conjugated Gold Nanorods for the Early Detection of High-Grade Bladder Cancer Residual Disease
    Authors: Not listed
    Year: 2025
    Citations: 1

  • Title: Bispecific aptamer-decorated and light-triggered nanoparticles targeting tumor and stromal cells in breast cancer derived organoids: implications for precision phototherapies
    Authors: Not listed
    Year: 2024
    Citations: 11

  • Title: Ferroptosis in Cancer: Epigenetic Control and Therapeutic Opportunities
    Authors: Not listed
    Year: Not available
    Citations: 6

  • Title: Subtype Transdifferentiation in Human Cancer: The Power of Tissue Plasticity in Tumor Progression
    Authors: Not listed
    Year: Not available
    Citations: 2

  • Title: Correction to: Bispecific aptamer-decorated and light-triggered nanoparticles targeting tumor and stromal cells in breast cancer derived organoids
    Authors: Not listed
    Year: 2024

  • Title: Correction to: Selective Photo-Assisted Eradication of Triple-Negative Breast Cancer Cells through Aptamer Decoration of Doped Conjugated Polymer Nanoparticles
    Authors: Not listed
    Year: 2022
    Citations: 1

Martina Torricelli | Biochemistry | Women Researcher Award

Published on by World Top Scientists

Dr. Martina Torricelli | Biochemistry | Women Researcher Award

Ricercatore sanitario at Istituto Zooprofilattico Sperimentale dell’Umbria e delle Marche “Togo Rosati”, Italy

Martina Torricelli is a dedicated biomedical researcher with over a decade of experience in molecular biology, biotechnology, and public health. She holds a PhD in Animal Health and Food Safety and is currently a permanent Research Scientist at the Istituto Zooprofilattico Sperimentale dell’Umbria e delle Marche. Her research spans molecular diagnostics, food safety, zoonotic diseases, and genetic studies in both human and veterinary contexts. Martina played a crucial role in the COVID-19 response through molecular testing and viral sequencing. She is also pursuing a specialization in Clinical Pathology and holds a Master’s in Health Management, reflecting her commitment to both scientific and organizational excellence. Her technical expertise includes real-time PCR, sequencing, and bioinformatics, supported by numerous national research projects. Passionate about science, she consistently contributes to scientific writing and project development. Martina exemplifies perseverance, scientific rigor, and a strong contribution to public health, making her a valuable figure in biomedical research.

Professional Profile

Scopus Profile
ORCID Profile

Education

Martina Torricelli has a comprehensive academic background in life sciences and biotechnology. She holds a PhD in “Animal Health, Livestock Production, and Food Safety” from the Faculty of Veterinary Medicine at the University of Perugia, where she conducted research at the Istituto Zooprofilattico Sperimentale dell’Umbria e delle Marche (IZSUM). She is also a licensed Biologist, having passed the national certification exam in 2014 and is registered in the Order of Biologists (Section A). To further enhance her clinical and diagnostic expertise, Martina enrolled in a specialization school in Clinical Pathology and Biochemistry and is currently in her third year. Complementing her scientific education, she obtained a Level II Master’s in Healthcare Management from the University “Niccolò Cusano” in 2024. Her academic achievements reflect a multidisciplinary approach that bridges research, diagnostics, and management, preparing her for both laboratory innovation and healthcare leadership roles.

Professional Experience

Martina Torricelli’s professional journey is rooted in research and diagnostic laboratories at the IZSUM, where she has built a solid reputation in molecular biology and biotechnology. With more than a decade of experience, she has held various research positions funded through scholarships and fixed-term contracts before earning a permanent role as a Research Scientist in 2024. Her work has involved developing and validating molecular techniques for detecting pathogens, food allergens, and genetic polymorphisms in both animal and food matrices. Notably, she contributed to Italy’s COVID-19 emergency response by performing molecular analysis and sequencing of SARS-CoV-2. Martina has led or contributed to several national projects, including genetic improvement in dairy herds and the study of Toll-like receptor polymorphisms in bovines. Her ability to bridge field diagnostics, laboratory innovation, and applied research showcases her versatility and reliability as a scientific professional in both public health and veterinary fields.

Research Interests

Martina Torricelli’s research interests focus on molecular diagnostics, genetic characterization, food safety, zoonotic diseases, and host-pathogen interactions. Her work reflects a strong commitment to improving both animal and public health through the application of cutting-edge biotechnological tools. She has worked extensively with PCR, real-time PCR, digital PCR, DNA sequencing, and in silico bioinformatic analysis. Notably, she has investigated SNP associations in immune-related genes, such as Toll-like receptors in cattle, and contributed to allergen detection and GMO studies in food. Her PhD and subsequent research emphasized translational science, connecting lab-based findings to real-world health applications. Martina is also passionate about One Health approaches, integrating veterinary and human diagnostics. She actively contributes to writing scientific papers and research proposals, further showing her commitment to academic dissemination and innovation. Her interests continue to evolve toward clinical pathology, supported by her current specialization studies, ensuring a well-rounded profile with both depth and adaptability.

Awards and Honors

While specific awards are not explicitly listed, Martina Torricelli’s career achievements and academic recognitions highlight a consistently excellent performance in the biomedical research field. She successfully obtained her PhD with top evaluations and earned national recognition by qualifying as a registered Biologist. Martina’s continuous receipt of competitive research fellowships at IZSUM for over a decade reflects institutional trust and recognition of her expertise and dedication. Her involvement in key national research projects—such as those focused on food allergen detection, genetic resistance in livestock, and SARS-CoV-2 diagnostics—demonstrates her reputation as a reliable and skilled scientist. Her recent promotion to a permanent Research Scientist position in 2024 further underlines the institutional value placed on her work. Additionally, her enrollment and success in the Clinical Pathology specialization and Health Management Master’s program showcase her drive to continuously expand her professional competence, making her a strong candidate for recognition such as the Women Researcher Award.

Conclusion

Martina Torricelli stands out as a passionate, driven, and well-rounded biomedical researcher whose work has significantly contributed to molecular diagnostics, public health, and veterinary science. Her extensive experience at IZSUM, participation in nationally significant projects, and evolving academic pursuits highlight her adaptability and continuous professional growth. She brings together technical expertise, collaborative spirit, and an interdisciplinary outlook aligned with the principles of One Health. Her dedication to scientific rigor, innovation, and her pivotal role during the COVID-19 pandemic further underscore her impact. Martina’s transition from scholarship-based roles to a permanent research position is a testament to her competence and commitment. With ongoing specialization in clinical pathology and advanced training in healthcare management, she is well-equipped for leadership in research and diagnostic innovation. These attributes collectively make her a highly deserving candidate for the Women Researcher Award, celebrating both her achievements and her potential for continued contributions to science and public health.

Publications Top Notes

  • Title: Gene Expression Study in Gilthead Seabream (Sparus aurata): Effects of Dietary Supplementation with Olive Oil Polyphenols on Immunity, Metabolic, and Oxidative Stress Pathways
    Authors: Torricelli, Martina; Felici, Andrea; Branciari, Raffaella; Ranucci, David; Agnetti, Francesco
    Year: 2024
    Source: International Journal of Molecular Sciences

  • Title: Terbinafine Resistance in Trichophyton Strains Isolated from Humans and Animals: A Retrospective Cohort Study in Italy, 2016 to May 2024
    Authors: Crotti, Silvia; Cruciani, Deborah; Sabbatucci, Michela; Spina, Sara; Piscioneri, Vincenzo; Torricelli, Martina; Calcaterra, Roberta; Farina, Claudio; Pisano, Luigi; PAPINI, Manuela
    Year: 2024
    Source: Journal of Clinical Medicine
    DOI: 10.3390/jcm13185493

  • Title: Evaluation of Single Nucleotide Polymorphisms (SNPs) Associated with Genetic Resistance to Bovine Paratuberculosis in Marchigiana Beef Cattle, an Italian Native Breed
    Authors: Mazzone, Piera; Di Paolo, Antonella; Petrucci, Linda; Torricelli, Martina; Corneli, Sara; Sebastiani, Carla; Ciullo, Marcella; Sebastianelli, Martina; Costarelli, Silva; Scoccia, Eleonora
    Year: 2023
    Source: Animals
    DOI: 10.3390/ANI13040587

  • Title: Porcine Reproductive and Respiratory Syndrome (PRRS) and CD163 Resistance Polymorphic Markers: What Is the Scenario in Naturally Infected Pig Livestock in Central Italy?
    Authors: Torricelli, Martina; Fratto, Anna; Ciullo, Marcella; Sebastiani, Carla; Arcangeli, Chiara; Felici, Andrea; Giovannini, Samira; Sarti, Francesca Maria; Sensi, Marco; Biagetti, Massimo
    Year: 2023
    Source: Animals
    DOI: 10.3390/ANI13152477

  • Title: Tapeworms Detected in Wolf Populations in Central Italy (Umbria and Marche regions): A Long-term Study
    Authors: Crotti, Silvia; Spina, Sara; Cruciani, Deborah; Bonelli, Piero; Felici, Andrea; Gavaudan, Stefano; Gobbi, Marco; Morandi, Federico; Piseddu, Toni; Torricelli, Martina
    Year: 2023
    Source: International Journal for Parasitology: Parasites and Wildlife
    DOI: 10.1016/J.IJPPAW.2023.03.007

  • Title: Genetic Characterization of Small Ruminant Lentiviruses (SRLVs) Circulating in Naturally Infected Sheep in Central Italy
    Authors: Arcangeli, Chiara; Torricelli, Martina; Sebastiani, Carla; Lucarelli, Daniele; Ciullo, Marcella; Passamonti, Fabrizio; Giammarioli, Monica; Biagetti, Massimo
    Year: 2022
    Source: Viruses
    DOI: 10.3390/V14040686

  • Title: Marker-assisted Selection of Dairy Cows for Beta-casein Gene A2 Variant
    Authors: Sebastiani, Carla; Arcangeli, Chiara; Torricelli, Martina; Ciullo, Marcella; D’avino, Nicoletta; Cinti, Giulia; Fisichella, Stefano; Biagetti, Massimo
    Year: 2022
    Source: Italian Journal of Food Science
    DOI: 10.15586/IJFS.V34I2.2178

  • Title: PRNP Polymorphisms in Eight Local Goat Populations/Breeds from Central and Southern Italy
    Authors: Torricelli, Martina; Sebastiani, Carla; Ciullo, Marcella; Ceccobelli, Simone; Chiappini, Barbara; Vaccari, Gabriele; Capocefalo, Antonio; Conte, Michela; Giovannini, Samira; Lasagna, Emiliano
    Year: 2021
    Source: Animals
    DOI: 10.3390/ANI11020333

  • Title: First Survey of SNPs in TMEM154, TLR9, MYD88 and CCR5 Genes in Sheep Reared in Italy and Their Association with Resistance to SRLVs Infection
    Authors: Arcangeli, Chiara; Lucarelli, Daniele; Torricelli, Martina; Sebastiani, Carla; Ciullo, Marcella; Pellegrini, Claudia; Felici, Andrea; Costarelli, Silva; Giammarioli, Monica; Feliziani, Francesco
    Year: 2021
    Source: Viruses
    DOI: 10.3390/v13071290

  • Title: Early Detection of Mycobacterium avium subsp. paratuberculosis Infected Cattle: Use of Experimental Johnins and Innovative Interferon-Gamma Test Interpretative Criteria
    Year: 2021
    Source: Frontiers in Veterinary Science
    DOI: 10.3389/fvets.2021.638890

  • Title: Frequencies Evaluation of Beta-Casein Gene Polymorphisms in Dairy Cows Reared in Central Italy
    Authors: Sebastiani, Carla; Arcangeli, Chiara; Ciullo, Marcella; Torricelli, Martina; Cinti, Giulia; Fisichella, Stefano; Biagetti, Massimo
    Year: 2020
    Source: Animals
    DOI: 10.3390/ANI10020252

  • Title: Sesame, Pistachio, and Macadamia Nut: Development and Validation of New Allergenic Systems for Fast Real-Time PCR Application
    Year: 2020
    Source: Foods
    DOI: 10.3390/foods9081085

  • Title: A Multi-screening Fast qPCR Approach to the Identification of Abortive Agents in Ruminants
    Year: 2018
    Source: Journal of Microbiological Methods
    DOI: 10.1016/J.MIMET.2018.03.009

  • Title: Digital PCR for Analysis of Peanut and Soybean Allergens in Foods
    Year: 2018
    Source: Food Control
    DOI: 10.1016/J.FOODCONT.2018.04.039

  • Title: Evaluation of Systems for Nopaline Synthase Terminator in Fast and Standard Real-Time PCR to Screen Genetically Modified Organisms
    Year: 2016
    Source: Food Analytical Methods
    DOI: 10.1007/S12161-015-0283-7

  • Title: In-house Validation of a DNA Extraction Protocol from Honey and Bee Pollen and Analysis in Fast Real-Time PCR of Commercial Honey Samples Using a Knowledge-Based Approach
    Year: 2016
    Source: Food Analytical Methods
    DOI: 10.1007/S12161-016-0539-X

 

 

Sevasti Matsia | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Published on by World Top Scientists

Dr. Sevasti Matsia | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Post Doctoral Researcher at  Aristotle University of Thessaloniki, Greece

Sevasti Matsia is a dedicated researcher in (Bio)inorganic Chemistry and Advanced Materials, currently affiliated with the Aristotle University of Thessaloniki (AUTh), Greece. With a strong passion for interdisciplinary scientific exploration, she has contributed significantly to the field of chemical engineering, focusing on innovative solutions for health-related applications. She has been actively engaged in both research and education, mentoring students while advancing her expertise in bioinorganic chemistry. Her professional journey reflects her commitment to academic excellence, scientific discoveries, and contributions to material sciences. Through her involvement in various scientific collaborations and conferences, she continues to expand her knowledge base and strives for impactful research that bridges fundamental science with practical applications.

Professional Profile

Education

Sevasti Matsia holds a Ph.D. in (Bio)inorganic Chemistry and Advanced Materials from Aristotle University of Thessaloniki, where she focused on insulin mimetic (nano)biotechnology of metal-flavonoid complexes and bioavailable propolis in Diabetes Mellitus II. Prior to her Ph.D., she earned an M.Sc. in “Processes and Technology in Advanced Materials” from the same institution, graduating with a commendable 8.88 GPA. She also holds a Diploma (Integrated Master’s) in Chemical Engineering, where she specialized in aqueous structural speciation and synthetic, physicochemical, and biological studies of boron/thallium hydroxycarboxylic acid binary systems. Her academic journey is marked by a deep interest in material sciences and bioengineering, paving the way for interdisciplinary research that combines chemistry, biology, and engineering to address critical biomedical challenges.

Professional Experience

Sevasti Matsia has been a Scientific and Educational Collaborator at Aristotle University of Thessaloniki since 2016, contributing to both undergraduate and graduate education. She has been involved in interdisciplinary research on biological engineering, focusing on the applications of advanced materials in medicine and health sciences. Her professional background includes voluntary participation in international scientific conferences, such as the European Congress and Exhibition on Advanced Materials and Processes (Euromat 2017), where she contributed to event organization. Additionally, she has industry experience through her practical training at Vosmandros, D. – “Smile Cosmetics” S.A., where she worked on the production of cosmetic products. Her diverse professional engagements showcase her ability to integrate research, education, and industrial applications to develop innovative solutions in material sciences and bioengineering.

Research Interests

Sevasti Matsia’s research primarily revolves around (bio)inorganic chemistry, nanobiotechnology, and advanced materials with applications in medicine and health sciences. She has focused on metal-flavonoid complexes, insulin-mimetic properties, and bioavailable propolis for treating Diabetes Mellitus II. Her expertise extends to thallium hybrid materials and their structurally dependent biotoxicity correlations in biological applications, providing valuable insights into material toxicity and therapeutic potential. Additionally, she has a strong interest in synthetic, physicochemical, and biological studies of metal-based compounds, aiming to bridge fundamental chemistry with biomedical advancements. Her research contributions lie at the intersection of chemistry, nanotechnology, and biomedicine, offering promising developments in drug delivery, biomaterials, and health-related applications.

Awards and Honors

While her profile highlights significant contributions to academia and research, Sevasti Matsia’s formal recognitions, awards, and honors are not explicitly mentioned in her resume. However, her achievements include high academic performance, active participation in international conferences, and contributions to scientific education and research at Aristotle University of Thessaloniki. Her involvement in prestigious scientific congresses and interdisciplinary research projects demonstrates her dedication to advancing the field of (bio)inorganic chemistry and advanced materials. Moving forward, securing research grants, patents, or international collaborations could further enhance her recognition in the scientific community. If she has received awards or distinctions, including research grants, conference recognitions, or fellowships, these should be highlighted to strengthen her academic and professional standing.

Conclusion

Sevasti Matsia is a strong candidate for the Best Researcher Award, particularly due to her advanced research in bioinorganic chemistry and contributions to academic teaching. However, to maximize her competitiveness, she should highlight her publication impact, research funding, and international collaborations. If she has notable publications or research grants, these should be explicitly mentioned in her application to strengthen her profile further.

Publications Top Noted

  • “Synthetic V(V)-peroxido-zwitterionic species catalyze benzene oxidation under mild reaction conditions”
    • Authors: Efrosini Kioseoglou, Sevasti Matsia, Vassilis Psycharis, P. Rigas, Athanasios Salifoglou
    • Journal: Journal of Molecular Structure
    • Year: 2025
    • Citations: 0
  • “Preparation, Characterization, and Testing of Compost Tea Derived from Seaweed and Fish Residues”
    • Authors: Andrei Moț, Oana Cristina Pârvulescu, Violeta Alexandra Ion, C. Răducanu, Alexandra Mocanu
    • Journal: Agronomy
    • Year: 2024
    • Citations: 0
  • “Suitability of Residues from Seaweed and Fish Processing for Composting and as Fertilizer”
    • Authors: Joshua Cabell, Susanne Eich-Greatorex, Violeta Alexandra Ion, Athanasios Salifoglou, Anne-Kristin Løes
    • Journal: Sustainability (Switzerland)
    • Year: 2024
    • Citations: 0
  • “Chemical and Biological Profiling of Fish and Seaweed Residues to Be Applied for Plant Fertilization”
    • Authors: Marios Maroulis, Sevasti Matsia, Georgios Lazopoulos, Anne-Kristin Løes, Athanasios Salifoglou
    • Journal: Agronomy
    • Year: 2023
    • Citations: 2
  • “Effects of Marine Residue-Derived Fertilizers on Strawberry Growth, Nutrient Content, Fruit Yield and Quality”
    • Authors: Ailin Moloșag, Oana Cristina Pârvulescu, Violeta Alexandra Ion, L.A. Bădulescu, Viorica Lagunovschi-Luchian
    • Journal: Agronomy
    • Year: 2023
    • Citations: 4
  • “Chemical reactivity profile of rare earth metal ions with flavonoids. From structural speciation to magneto-optical properties”
    • Authors: Sevasti Matsia, Georgios Lazopoulos, Antonios Hatzidimitriou, R. Pöttgen, Athanasios Salifoglou
    • Journal: Polyhedron
    • Year: 2023
    • Citations: 0
  • “Selective antimicrobial food packaging of composite poly(lactic acid) cobalt-citrate films”
    • Authors: Konstantinos Rogkotis, Sevasti Matsia, Eleni Likotrafiti, C. Ritzoulis, Athanasios Salifoglou
    • Journal: Food Packaging and Shelf Life
    • Year: 2022
    • Citations: 5
  • “Antimicrobial Activity of Cobalt (II)-Citrate against Common Foodborne Pathogens and Its Potential for Incorporation into Food Packaging Material”
    • Authors: J. Rhoades, Vasiliki Katsouda, Sevasti Matsia, Athanasios Salifoglou, Eleni Likotrafiti
    • Journal: Applied Sciences (Switzerland)
    • Year: 2022
    • Citations: 0
  • “A unique ternary Ce(III)-quercetin-phenanthroline assembly with antioxidant and anti-inflammatory properties”
    • Authors: Efthymios Halevas, Sevasti Matsia, Antonios Hatzidimitriou, G. Litsardakis, Athanasios Salifoglou
    • Journal: Journal of Inorganic Biochemistry
    • Year: 2022
    • Citations: 9
  • “Chromium Flavonoid Complexation in an Antioxidant Capacity Role”
    • Authors: Sevasti Matsia, Olga Tsave, Antonios Hatzidimitriou, Athanasios Salifoglou
    • Journal: International Journal of Molecular Sciences
    • Year: 2022
    • Citations: 6

 

Rosa María Martínez-Espinosa | Biochemistry | Best Researcher Award

Published on by World Top Scientists

Prof Dr. Rosa María Martínez-Espinosa | Biochemistry | Best Researcher Award

Prof, University of Alicante, Spain

Dr. Rosa María Martínez-Espinosa, born in Alicante, Spain, is a distinguished biochemist and full professor at the University of Alicante. She leads the Applied Biochemistry Research Group and is well-known for her extensive research on extremophiles and their industrial applications. Dr. Martínez-Espinosa has made significant contributions to biotechnology, with over 100 publications in indexed journals, more than 200 conference presentations, and 70 book chapters. She also serves as the Vice President for International Relations and Development Cooperation at the University of Alicante. 🌍🔬

Publication Profile

ORCID

Education

Dr. Martínez-Espinosa earned her PhD in Biology from the University of Alicante in 2003, where she was awarded the Extraordinary Doctorate Award. She previously completed her BSc (Hons) in Biology at the same institution in 1998. 🎓📚

Experience

Dr. Martínez-Espinosa has held various academic positions at the University of Alicante since 2001. She began as an associate professor, advancing to senior lecturer and eventually full professor in 2020. Alongside her teaching, she has served in multiple leadership roles, including Vice-Dean for Postgraduate Programs and Vice-President for International Relations. She has also conducted research at the University of East Anglia, UK, during multiple research visits. 💼🏫

Research Focus

Her research focuses on the metabolism of extremophiles, biotechnological applications of microorganisms, enzyme purification, genetic manipulation of microorganisms, carotenoid production, and environmental bioremediation. Her work is funded by European and national grants, contributing to advances in microbial biotechnology and bioengineering. 🔬🧪

Awards and Honours

Dr. Martínez-Espinosa has been recognized with numerous accolades, including the 2024 Sprint-Valoriza Award for her project on Microbial Biotechnology, multiple Top Reviewer Awards by Web of Science in Biochemistry, Genetics, and Molecular Biology, and the 2013 Excellence in Teaching Award from the University of Alicante. 🏆🎖️

Publication Top Notes

Halocins and C<sub>50</sub> Carotenoids from Haloarchaea: Potential Natural Tools against Cancer

Production of Poly(3-hydroxybutyrate-<i>co</i>-3-hydroxyvalerate) (PHBV) by <i>Haloferax mediterranei</i> Using Candy Industry Waste as Raw Materials

Controversy over the Use of “Shade Covers” to Avoid Water Evaporation in Water Reservoirs